Abstract
Prenatal maternal distress is associated with an at-risk developmental profile, yet there is little fetal evidence of this putative in utero process. Moreover, the biological transmission for these maternal effects remains uncertain. In a study of n = 125 pregnant adolescents (ages 14–19), ambulatory assessments of daily negative mood (anger, frustration, irritation, stress), physical activity, blood pressure, heart rate (every 30 min over 24 hr), and salivary cortisol (six samples) were collected at 13–16, 24–27, 34–37 gestational weeks. Corticotropin-releasing hormone, C-reactive protein, and interleukin 6 from blood draws and 20 min assessments of fetal heart rate (FHR) and movement were acquired at the latter two sessions. On average, fetuses showed development in the expected direction (decrease in FHR, increase in SD of FHR and in the correlation of movement and FHR (“coupling”)). Maternal distress characteristics were associated with variations in the level and trajectory of fetal measures, and results often differed by sex. For males, greater maternal 1st and 2nd session negative mood and 2nd session physical activity were associated with lower overall FHR (p <.01), while 1st session cortisol was associated with a smaller increase in coupling (p <.01), and overall higher levels (p = .05)—findings suggesting accelerated development. For females, negative mood, cortisol, and diastolic blood pressure were associated with indications of relatively less advanced and accelerated outcomes. There were no associations between negative mood and biological variables. These data indicate that maternal psychobiological status influences fetal development, with females possibly more variously responsive to different exposures.
Keywords: fetal development, prenatal stress, distress, cortisol, heart rate variability
Introduction
Consistent with a developmental focus on the etiology of mental disorders (Insel, 2010), mounting evidence indicates that prenatal exposure to maternal distress1 exerts pervasive effects on infant and child physiology, behavior, and neurobehavioral trajectories (Bale et al., 2010; Charil, Laplante, Vaillancourt, & King, 2010; O'Connor, Heron, Golding, Beveridge, & Glover, 2002). This research rests on the premise that pregnant women's experiences alter fetal development, yet comparatively few studies have assessed the fetus to substantiate this putative in utero process. Moreover, the limited number of fetal studies fail to identify a biological mediator between maternal psychosocial functioning and outcomes (Glynn & Sandman, 2012; Monk et al., 2004), which may reflect assessment methods that could be improved with daily ambulatory monitoring of maternal distress and biological variables acquired multiple times over pregnancy.
Neurobehavioral assessment before birth, including fetal heart rate (FHR), fetal heart rate variability (FHRV), and the cross correlation between fetal movement (FM) and FHR, “coupling,” (Baser, Johnson, & Paine, 1992; DiPietro, 2005; DiPietro, Hodgson, Costigan, & Johnson, 1996b), provides an index of fetal ANS and CNS development. These parameters show consistent development patterns over pregnancy: decreasing FHR, increasing FHRV, and coupling. Maturation of the parasympathetic innervation of the heart accounts for some of these well-documented changes (Dalton, Dawes, & Patrick, 1983; Freeman, Garite, Nageotte, & Miller, 2012) while the increase in coupling reflects the development of the CNS and its coordination of the autonomic and somatic systems (Baser et al., 1992; Dipietro, Irizarry, Hawkins, Costigan, & Pressman, 2001; DiPietro et al., 2010, 1996b).
Prior studies relate maternal distress to variability in these fetal behaviors: stress to lower levels of 2nd and 3rd trimester FHRV (DiPietro, Hodgson, Costigan, & Hilton, 1996c) and coupling (DiPietro et al., 1996b); depression to slower return to 3rd trimester baseline FHR following vibro acoustic stimulation applied to the women's abdomen (Allister, Lester, Carr, & Liu, 2001; Dieter, Emory, Johnson, & Raynor, 2008). Low socio-economic status also has been associated with lower 2nd and 3rd trimester FHRV (Pressman, DiPietro, Costigan, Shupe, & Johnson, 1998). To date, maternal mood has not been examined in relation to the rate of the expected developmental changes in these fetal behaviors. For this report, both average levels of fetal parameters, and their trajectories, are studied.
The hypothesis that maternal distress is biologically transmitted to the fetus, and thereby influences fetal development finds support in studies demonstrating acute changes in FHR, FHRV, and FM to evoked maternal experience (DiPietro, Costigan, Nelson, Gurewitsch, & Laudenslager, 2008b; DiPietro, Costigan, & Gurewitsch, 2003). These data suggest that fetuses “register” women's reactions (DiPietro et al., 2003), which may, via physiological activation, serve as sensory stimuli (Novak, 2004). Throughout gestation, fetal development is thought to be shaped by these mood-associated alterations in women's biology via adaption to activation patterns and/or the direct influence of some of these biological systems (DiPietro et al., 2008a, 2003; Monk et al., 1998, 2004; Novak, 2004). The maternal ANS/cardiovascular and HPA axis systems are two primary biological effectors of emotion experiences that are potential mediators affecting fetal neurodevelopment through auditory and somatosensory stimulation, (e.g., auditory stimuli from the cardiovascular and gastrointestinal systems, somatosensory activation from changes in breathing rate and thermodynamics), changes in vascular flow and oxygenation, or cortisol exposure that targets glucocorticoid receptors in the fetal CNS and the developing HPA axis (for a review see (Owen, Andrews, & Matthews, 2005)).
In line with this biological transmission model, one report showed higher maternal cortisol was associated with greater amplitude and amount of 3rd trimester FM (DiPietro, Kivlighan, Costigan, & Laudenslager, 2009) while higher cortisol at 15 weeks predicted inadequate development of 2nd trimester FM response to stimulation (Glynn & Sandman, 2012). Higher 3rd trimester CRH (from blood assays, which reflects placenta production that can be enhanced via maternal cortisol levels (Goland et al., 1993; Robinson, Emanuel, Frim, & Majzoub, 1988)) was associated with diminished habituation in the FHR response to a series of vibro acoustic stimulations (VAS) (Sandman, Wadhwa, Chicz-DeMet, Porto, & Garite, 1999a). We found higher 3rd trimester cortisol and higher systolic blood pressure were associated with higher overall FHR (Monk, Myers, Sloan, Ellman, & Fifer, 2003). DiPietro et al. reported that average maternal and fetal heart rates were correlated from 32 weeks on (DiPietro, Irizarry, Costigan, & Gurewitsch, 2004a). Another biological effector of stress and distress, immune activation, has not yet been included in studies of fetal motor and ANS development, despite mounting evidence from animal models and human epidemiological studies demonstrating a critical role for maternal immune functioning in many neurodevelopmental disorders (Bilbo, 2012; Mehler et al., 1995; Merrill, 1992). In this report, we included assessment of maternal blood pressure, heart rate, HPA, and immune activation.
There are, at best, only marginal associations between pregnant women's reports of their psychological experience and indicators of biological activation (Fink et al., 2010; Huizink, Robles de Medina, Mulder, Visser, & Buitelaar, 2003; Monk et al., 2000; Ponirakis, Susman, & Stifter, 1998; Rieger et al., 2004), which has limited the possibility of identifying a biological mediator of the maternal mood effects on the fetus. Instead, the biological and psychological variables frequently are found to be uncorrelated, or independently associated with offspring development (Baibazarova et al., 2013; Davis et al., 2007; Davis & Sandman, 2010; Harville et al., 2009; Huizink, 2003). Recent research on distress during pregnancy (Entringer et al., 2012; Kaplan et al., 2012; Spicer et al., 2013) utilizes ecological momentary assessment (EMA) of emotional experiences via a personal digital assistant (PDA) multiple times a day (Entringer, Buss, Andersen, Chicz-DeMet, & Wadhwa, 2011; Giesbrecht, Campbell, Letourneau, & Kaplan, 2013) coupled with ambulatory collection of biological data. Ambulatory assessment may increase the possibility of finding mediating processes given its improved validity (in the moment responses versus the state-dependent recall of self-report questionnaires (Shiffman, 1997) and greater reliability (multiple measurements throughout the day). To that end, EMA, and ambulatory collection of cortisol, heart rate, and blood pressure are used in this study.
Two added questions in prenatal research that inform this study are the potentially differential influences related to the timing of the in utero distress exposure, and possible sex effects. Timing results have been somewhat variable across studies, some showing early to mid gestation as associated with a significant influence across a range of outcomes (attention, physical maturation, risk for schizophrenia) (Davis & Sandman, 2010; Ellman et al., 2008; Khashan et al., 2008; Laplante, Brunet, Schmitz, Ciampi, & King, 2008; Schneider, Roughton, Koehler, & Lubach, 1999) and others suggesting later effects, also evidenced in different results (e.g., mental development, mixed handedness) (Huizink et al., 2003) (Buss et al., 2009; Obel, Hedegaard, Henriksen, Secher, & Olsen, 2003; Sandman et al., 1991). With respect to sex, recent findings suggest that both sex-specific placental responsivity to maternal distress, in addition to hormones related to the sex of the offspring, may contribute to greater male vulnerability and consequences (Bale et al., 2010; Clifton, 2010; Mueller & Bale, 2008; Stark, 2009), while females, according to a recently advanced perspective, initially may adapt to in utero adversity, though at a cost of negative health consequences later in life (Sandman, Glynn, & Davis, 2013).
Finally, two different conceptual models have guided the investigation and interpretation of maternal prenatal distress effects: maternal factors could be conceptualized as follows: (1) teratogenic and altering offspring outcomes in ways consistent with a risk phenotype; or (2) telegrams, communicating to the fetus information of an adverse postnatal environment, justified via evolutionary biology to influence development to optimize infant adaptation to it. The first approach hypothesizes that atypical fetal outcomes indicate an increased risk of future psychopathology; in the latter, fetal development is accelerated to reduce exposure to a nonoptimal in utero experience and reduce maternal investment in an offspring with fewer chances for postnatal survival (Gluckman, 2005; Pike, 2005). Until recently (Sandman, Davis, & Glynn, 2012), the majority of fetal studies, including our own (Monk et al., 2000, 2004, 2010), have focused on the identification of an at-risk phenotype and that approach informed the hypotheses in this study.
The purpose of this report was twofold: (1) investigate the understudied though implicit hypothesis that maternal distress is associated with variation in key indices of fetal development and (2) consider a broad range of biological effectors of maternal distress as possible mediators transmitting maternal experience to the fetus. In this prospective research spanning the 1st to the 3rd trimesters, we studied pregnant adolescents as a sample skewed towards higher rates of psychosocial challenges and distress symptoms (Caldwell & Antonucci, 1997; Kovacs, Krol, & Voti, 1994). Based on prior research (Glynn & Sandman, 2012), we anticipated that higher maternal daily distress and elevated cortisol early in pregnancy would be associated with overall (1) higher FHR, lower FHRV, and less coupling, and, (following (Dipietro et al., 2004)) altered developmental trajectories, specifically, (2) a smaller decrease in FHR, and reduced increases in FHRV and coupling from mid to late pregnancy. Following prior research (Bale et al., 2010; Clifton, 2010; Mueller & Bale, 2008; Stark, 2009), we anticipated effects in both sexes, but predicted male versus female fetuses would show larger effects. Because there are few studies of maternal cardiovascular and immune activity in relation to human fetal behavior these variables made up exploratory aims.
Methods
Participants
Healthy nulliparous pregnant adolescents, ages 14–19 were recruited through the Departments of Obstetrics and Gynecology at Columbia University Medical Center (CUMC) and Weill Cornell Medical College, and flyers posted in the CUMC vicinity. Adolescents were excluded if they acknowledged smoking or use of recreational drugs, lacked fluency in English or on the basis of frequent use of: nitrates, steroids, beta blockers, triptans, and psychiatric medications. Of the 325 adolescents referred to the study, 40 were not screened (15 non-English speaking, 18 unable to be reached, four declined to be screened, three other); 285 were screened and 205 enrolled following exclusion based on ineligibility (n = 27) or failure to attend enrollment session (n = 53). All enrolled participants provided written-informed consent, and all procedures were approved by the Institutional Review Board of the New York State Psychiatric Institute/CUMC and Weill Cornell Medical College.
Study Procedures
There were a total of three study sessions that occurred at gestational weeks 13–16 (1st), 24–27 (2nd) and 34–37 (3rd) (see Fig. 1). One-hundred and fifty-three subjects enrolled in the 1st session and 52 enrolled in the 2nd. Each study session involved three consecutive days of assessment and included the collection of: 24 hr ambulatory blood pressure (ABP) and heart rate (HR) monitoring, 24 hr EMA of mood, and 48 hr salivary cortisol; medical data on pregnancy course (and later, birth outcomes) culled from participants' medical charts, and questionnaires about health and mood. At the 2nd and 3rd sessions, blood was drawn for immune markers and CRH, and fetal data were collected. To accommodate participants, sessions were scheduled in the late morning and afternoons; we aimed to keep the time of sessions consistent throughout study participation. There was one, randomly scheduled, urine toxicology screen to test for use of cannabinoids, amphetamines, benzodiazepines, opioids, and cotinine.
Figure 1.
Diagram of study protocol.
Ambulatory Blood Pressure and Heart Rate
Measures of systolic and diastolic ABP and HR were collected every 30 min for 24 hr periods using the Spacelabs Healthcare #90207 Ambulatory Blood Pressure (ABP) Monitor (Spacelabs Healthcare, Snoqualmie, WA). On the 1st day of each study session, the ABP cuff and monitor were fitted to the participant (Beevers, Lip, & O'Brien, 2001). Adjustments with ABP equipment were made until two automated readings fell within ± 10 mm Hg of two manual ones. Participants were asked not to remove the ABP monitor during each 24 hr testing period.
EMA of Mood and Activity
Using a Personal Digital Assistant (PDA), (Palm, Inc. Tungston E2 Handheld, Sunnyvale, CA) participants completed an EMA of mood and physical activity ratings every 30 min for 24 hr periods, excluding sleeping time. Participants were instructed to complete assessments throughout the day, concurrently with automated ABP readings, using the inflation of the ABP unit as a prompt. Directions for each assessment reminded participants to report their moods and experiences at that moment. Participants completed ratings of 18 mood states, following other research using EMA mood assessment with adolescents (Adam, 2006; DeSantis et al., 2007): cheerful, lonely, nervous, cooperative, angry, responsible, frustrated, competitive, strained, worried, caring, irritated, relaxed, stressed, proud, friendly, hard working, productive (see below for the calculation of the “negative mood” variable). Participants used a four point Likert scale to complete all mood ratings, with one being “not at all (e.g., cheerful; active)” and four being “very much; the most (e.g., cheerful; active) you can imagine.” Participants also provided a rating of their current physical activity level to control for its affect on ABP values as well as its possible associations with fetal outcomes. Participants were instructed to report activity on a four point scale, “with four being the most active you can imagine, and one being the least active you can imagine.” At the 1st session, participants went through a practice assessment with research staff to ensure correct device use, as well as comprehension of the vocabulary, and rating scale. All EMA responses were automatically time-stamped, stored on the PDA, and uploaded to a server when participants returned devices to the lab.
Salivary Cortisol
Forty-eight hour salivary cortisol collection was timed to begin during the 1st day of each study session. Subsequent samples on the 2nd day of collection were as follows: at waking; 45 min, 2.5 hr, 3.5 hr, and 8 hr after waking; and at 10 PM or before going to bed. Cotton used for each sample was kept in a bottle with a Medication Event Monitoring System (MEMS) track cap (Aardex, Union City, CA), which records the time of opening and has been shown to help adolescents comply with sampling protocols (Adam & Kumari, 2009). Once used, the cotton was placed in a Salivette tube (Sarstedt, Newton, NC). After return to the lab, samples were kept frozen at −80°C until assayed using a commercial ELISA/ EIA kit optimized for saliva (Salimetrics, State College, PA).
Immune Markers and CRH
Ten milliliter blood samples were collected in EDTA tubes. Samples were placed on ice, spun down, and frozen at −80°C within 60 min of collection. IL–6 and CRP were assayed using high sensitivity commercial ELISA kits (HS-IL–6: R + D Systems, Minneapolis, MN; Zymutest HS-CRP: Diapharma, West Chester, OH). Plasma CRH was measured by radioimmunoassay following a methanol extraction. One milliliter of each plasma sample was mixed with 4 ml ice-cold methanol in glass tubes, vortexed for 1 min and incubated on ice for 20 min. Tubes were spun at 3,500rpm for 15 min at 4°C. The top layer was transferred to a clean glass tube on ice .5 ml of ice-cold methanol was added to the remainder pellet, vortexed and spun again at 3,500 rpm for 15 min at 4°C. The top layer was added to the first removed alliquot and dried in a vacuum centrifuge. The samples were reconstituted in 500 μl assay buffer (.063 M Na2HPO4, .13 N Na2EDTA, .02% NaN3, .1% Triton X-100, normal rabbit serum 1% and 25 mg/l aprotinin) incubated for 2hr on ice and vortexed. CRF standards (Sigma–Aldrich, St Louis, MO) were prepared at 20–2,500 pg/ml. CRF antibody (Abcam, San Francisco, CA) was diluted (1:10) to produce 25–30% binding with CRH tracer and 100 μl of CRH antibody was incubated with 100 μl of standards and samples for 48 hr. CRF tracer from New England Nuclear (Boston, MA) was diluted in assay buffer to 3,000 counts per 100 μl and incubated with samples for and additional 24 hr. Fifty microliter goat anti-rabbit secondary antibody (IgG Corp, Nashville, TN) diluted 1:1 with assay buffer without normal rabbit serum, triton X or aprotinin was added for 12hr. Then samples were centrifuged at 2,000g for 20 min, liquid aspirated and radioactivity of pellets counted in a gamma counter. Samples were run in one of two assays, with both samples from any one subject run within the same assay. A third assay was run to further dilute samples with concentrations above the standard curve. All samples were run in duplicate and standards in triplicate. Extraction efficiency was 70%. The detection limit was 20 pg/ml and intra-assay coefficient of variation was <10%. The inter-assay coefficients of variation were 4–11%.
Fetal Assessment
For the fetal assessment, participants were in a semi-recumbent position for 20 min as FM and FHR were acquired on the 1st day of the 2nd and 3rd sessions. Data were obtained using a Toitu MT 325 fetal actocardiograph (Toitu Co., Ltd, Tokyo, Japan). The Toitu detects FHR and FM via a single transabdominal Doppler transducer and processes this signal through a series of filters. The detection of FM uses these filters to remove frequency components of the Doppler signal that are associated with FHR and maternal somatic activity, and has been shown to be reliable (Besinger & Johnson, 1989; Dipietro et al., 2004b; DiPietro, Costigan, & Pressman, 1999).
FHR and FM data were collected from the output port of the Toitu MT 325 and digitized at 50 Hz using a 16 bit A/D card (National Instruments 16XE50). Data were analyzed offline using custom Matlab programs (http://www.math-works.com/) developed for this project. Three fetal variables were of interest: mean FHR; standard deviation of FHR (FHRSD, our index of FHRV); and FM/FHR cross-correlation (“coupling”). As a first step in preprocessing, FHR below 80 beats per minute (bpm) or above 200 bpm was linearly interpolated and then low-pass filtered at 3 Hz using a 16 point finite impulse response filter. Mean and standard deviation of the resulting FHR were taken over non-interpolated values. Filtered FHR was further examined for artifact in the following way: times at which the absolute sample-to-sample (20 ms) change in FHR exceeded 5bpm were found and FHR was marked as artifact until it returned to within 5 bpm of the previous value. The resultant gaps were linearly interpolated.
Because the FHR/FM coupling of interest occurs on time scales fewer than 4 min, we estimated cross-correlation of FHR and FM for the entire record by averaging cross-correlations taken for 4 min overlapping (50%) segments. This is akin to averaging over FFT's in the Welch method of power spectrum estimation (Bendat, 2000). FHR-FM cross-correlations were computed as follows: (1) FHR and FM over the entire record were first bandpass filtered between .002 and .05Hz using a 400 point FIR filter; (2) FHR was further smoothed by subtracting a local regression of 10% span; (3) decelerations of FHR were set to zero; (4) FM was z-scored (Dipietro, Irizarry, Hawkins, Costigan, & Pressman, 2001). Before taking the cross-correlation for each 4 min segment, a Hanning window was applied. Based upon visual inspection of hundreds of similar studies, our group has developed criteria used to screen data for artifact. Specifically, individual segments were excluded from the average if any of three conditions applied: (1) total interpolated FHR exceeded 50% of segment length; (2) an interpolated gap of greater than 30 s occurred; (3) cumulative time of interpolated gaps between 2s and 30 s exceeded 1min. As an aid to post-processing, the mean percentage of interpolated data within each segment and the number of non-excluded segments were recorded. Finally, as a further control for artifact, any segment with maximum cross-correlation at a lag of less than −15 s or greater than 0 s was not included in the average spectral power or cross-correlation calculation because true physiological FHR-FM coupling is within this range, with FM leading FHR (DiPietro et al., 1996b).
Pregnancy Health and Birth Outcomes
Infection during pregnancy (yeast, urinary tract infections) yes/no was ascertained from the medical record and subject report at each study session. Gestational age at birth, birth-weight, pregnancy complications, C-section, and sex of the infant, were determined from the medical record. Pregnancy complications were defined as preeclampsia/hypertension, vascular issues, diabetes mellitus, and other; the number of complications were summed and then dummy coded according to three dichotomous classifications: 0, 1–4, ≥5. Gestational age at study sessions was determined based on ultrasound examinations and last reported menstrual cycle. Body mass index (BMI) was calculated using pre-pregnancy weight from self-report and measured height, both ascertained at the enrollment session.
Data Transformation and Analysis Plan
Preliminary analyses were performed to identify maternal variables that might influence fetal measures including infection status, BMI, maternal age, ethnicity, pregnancy complications, and physical activity. Pre-pregnancy BMI, pregnancy complications, and physical activity were associated with FHR and FHRSD (p < .05). Maternal age had a marginally significant association with FHR (p = .13). As other studies on fetal development have included maternal age as a covariate (Dipietro et al., 2004; DiPietro et al., 1996b), and it has been a significant covariate in another study with pregnant adolescents (despite the constricted range) (Spicer et al., 2013), it was included in statistical models, along with the other variables showing significant associations.
Of the 205 enrolled pregnant adolescents, the following data were missing from participants so that we excluded these participants from analyses: fetal data at both time points (60), pregnancy complications (15), BMI (3), maternal age (2), resulting in a sample of 125 for this study.
To create an index of EMA distress, hereafter called negative mood, all items from the mood assessments were entered into an exploratory factor analysis using maximum likelihood estimation as the fitting method. Items with loadings below .4 were excluded from further analysis. The negative mood index at each time point was calculated based on the average of the following items: angry, frustrated, irritated, and stressed. A participant's average physical activity level for each session period was calculated by summing all values reported and dividing it by the number of total responses completed over a 24 hr period. Cortisol area under the curve (AUC) (Fekedulegn, 2007), used to index HPA axis activity, was calculated from the wake up time to going to bed on the 2nd day of collection because the 2nd day included a time-based, uniform protocol. For inclusion in AUC analyses, the following was required: at least 4/6 cortisol samples, the 1st wake up collection, and ≥8hr time span from first to last sample. For 1st session AUC, 10 values did not reach these criteria; for the 2nd and 3rd sessions, six did not. Cortisol AUC and CRH data from all three sessions were not normally distributed. Prior to inclusion in analyses these variables were log transformed and satisfied normality, assessed by the Kolmogorov–Smirnov test (Conover, 1971).
To evaluate if maternal and fetal variables changed across pregnancy, we used linear mixed effect analyses by treating time as both continuous (gestational week) and categorical (1st, 2nd, 3rd session) variables. To test for associations between maternal negative mood and biological variables, we used Spearman's rank-order correlation analyses. To determine which maternal variables should be included in models of fetal outcomes (in addition to our a priori ones, negative mood, and cortisol), Spearman's rank-order correlation analysis were used to find associations between CRH, CRP, IL6, ABP, HR, and fetal outcomes.
To test the effects of maternal negative mood and biology on fetal development across pregnancy, hierarchical liner models (HLM) (Raudenbush, 2004) were used. We constructed separate two-level models to evaluate the associations between the maternal variables and fetal trajectories. First, we tested if maternal negative mood and/or biology (cortisol, etc.) variables were associated with the status, average level, of fetal measures across the 2nd and 3rd sessions by modeling the random intercept, and whether the timing of the maternal effect (1st or 2nd session values) was significant. Alteration of the rate of developmental change in fetal measures by those maternal variables was tested by modeling the random slope. Additionally, we tested the moderation effect of fetal sex. In the hierarchical models, fetal gestational age, two of the covariates (maternal age, pre-pregnancy BMI), and all predictors were centered by subtracting their overall means. To test goodness-of-fit of the models, likelihood ratio tests, and residual analyses were conducted.
All statistical analyses were performed using SAS 9.3. The residuals of the hierarchical models were normally distributed and did not show any structured pattern. All tests were two-tailed with a at .05 and only significant models are reported (Likelihood-ratio test of p < .05).
Results
Participants
Table 1 shows descriptive data. Twelve infants had birth weights <2,500 g or gestational age at birth <37 weeks. Reported results did not change when models were re-run to exclude these fetuses. One participant included in analysis tested positive for cannabinoids during pregnancy.
Table 1. Descriptive Statistics.
Variables | N | Mean/% | StdDev | Min | Max |
---|---|---|---|---|---|
Maternal | |||||
Age | 125 | 17.80 | 1.16 | 14 | 19 |
Pre-Pregnancy BMI (kg/m2) | 125 | 25.68 | 6.00 | 16.57 | 47.60 |
Ethnicity | |||||
Hispanic | 111 | 89 | |||
Non-Hispanic | 14 | 11 | |||
Pregnancy Complicationsa | |||||
None | 65 | 52 | |||
1, 2, or 3 complications | 30 | 24 | |||
5 complications | 30 | 24 | |||
C-Section | |||||
No | 93 | 74 | |||
Yes | 32 | 26 | |||
Infectionb | |||||
No | 71 | 57 | |||
Yes | 54 | 43 | |||
Negative Mood–avg#of entries/24 hrd | 125 | 19.75 | 8.12 | 3 | 59 |
Cortisol–avg#of samples 2nd dayc,d | 122 | 5.75 | 0.53 | 4 | 7 |
ABP–avg#of values/24 hrd | 125 | 35.52 | 9.59 | 10.67 | 50.33 |
Fetal | |||||
Birthweight (grams)e | 123 | 3230.52 | 513.02 | 947.00 | 4525.00 |
Gestational age at Birth (weeks) | 123 | 39.17 | 2.03 | 26.57 | 41.57 |
Sex | |||||
Male | 79 | 63 | |||
Female | 46 | 37 |
StdDev, standard deviation; Min, minimum; Max, maximum; BMI, body mass index; Negative mood, ecological momentary assessment negative mood; ABP, ambulatory blood pressure.
Defined as preeclampsia/hypertension, vascular issues, diabetes mellitus, and other(s).
Defined as yeast and/or urinary tract infections.
Four participants at the 1st session, six at the 2nd, and nine at the 3rd provided a total of seven saliva samples on the 2nd day instead of the requested six.
These results are the value per assessment period (24hr or 2nd study day) averaged over the three study sessions across pregnancy.
Twelve of 123 infants had birth weights <2,500g or gestational age at birth <37 weeks. Reported results did not change when models were re-run to exclude these 12.
Compliance With Ambulatory Assessments
As shown in Table 1, participants had good compliance with the ambulatory assessments. With respect to the diary reporting, the average of nearly 20 entries over 24 hr periods suggests almost one entry every 30 min (as requested) excluding sleeping hours. For cortisol, an average of almost six samples for the 2nd day of collection also shows overall good conformity with the study protocol.
Maternal Negative Mood and Biology Over Gestation
Table 2 shows average values for maternal negative mood and biological variables across the study sessions. Negative mood (β = .02, p = .40) and physical activity (β = .01, p = .57) and CRP (β = −1.01, p = .12) did not change significantly over time. All other variables showed significant increases (AUC log cortisol, diastolic ABP, HR, IL6, and log CRH (p ≤ .01)). Finally, of note, there is significant variability in the range of negative mood scores.
Table 2. Maternal and Fetal Variables.
1st Session (13–16 weeks) | 2nd Session (24–27 weeks) | 3rd Session (34–37 weeks) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||||||
Variables | N | Mean | StdDev | Min | Max | N | Mean | StdDev | Min | Max | N | Mean | StdDev | Min | Max |
Maternal | |||||||||||||||
Negative Mood | 96 | 1.42 | .43 | 1.00 | 2.89 | 116 | 1.48 | .56 | 1.00 | 3.92 | 111 | 1.50 | .58 | 1.00 | 3.83 |
Physical Activity | 96 | 1.71 | .53 | 1.00 | 4.00 | 116 | 1.74 | .54 | 1.00 | 4.00 | 111 | 1.75 | .63 | 1.00 | 4.00 |
HR | 95 | 85.45 | 7.35 | 66.47 | 107.80 | 114 | 90.95 | 8.11 | 61.60 | 113.55 | 114 | 92.04 | 8.66 | 61.07 | 120.00 |
Diastolic BP | 95 | 80.98 | 5.10 | 70.98 | 94.72 | 114 | 82.74 | 5.57 | 69.87 | 103.21 | 114 | 87.48 | 14.30 | 66.00 | 219.00 |
Cortisol (μg/dl)a | 79 | 2.44 | 1.16 | .56 | 7.84 | 106 | 2.97 | 1.03 | 1.04 | 6.68 | 97 | 3.50 | 1.34 | 1.53 | 9.45 |
CRH (pg/ml)b | 99 | 150.63 | 97.86 | 18.00 | 419.00 | 99 | 1026.76 | 610.32 | 80.00 | 2785 | |||||
CRP(mg/dL) | 108 | .86 | .95 | .03 | 4.65 | 104 | .74 | .60 | .001 | 2.91 | |||||
IL-6 (pg/mL) | 108 | 1.65 | 1.23 | .28 | 7.54 | 104 | 2.06 | 1.26 | .57 | 7.54 | |||||
Fetalc | |||||||||||||||
FHR | 95 | 145.86 | 5.48 | 132.94 | 155.39 | 108 | 142.29 | 6.23 | 128.80 | 155.49 | |||||
FHRSD | 92 | 6.65 | 2.39 | 3.65 | 17.77 | 104 | 7.79 | 2.28 | 3.26 | 15.23 | |||||
Coupling | 59 | .49 | .11 | .26 | .76 | 82 | .56 | .10 | .31 | .78 |
StdDev, standard deviation; Min, minimum; Max, maximum; HR, heart rate; CRH, corticotropin releasing hormone; CRP, C-reactive protein; IL-6, Interleukin 6; FHR, fetal heart rate; FHRSD, fetal heart rate standard deviation.
Area under the curve. Raw values.
Raw values.
Using two SD, outlier fetal values were excluded from analysis: six from FHR 2nd session, six from FHR 3rd session, five from FHRSD 2nd session, eight from FHRSD 3rd session, four from coupling 2nd session, three from coupling 3rd session.
Fetal Measures Over Gestation
As predicted, on average FHR decreased over pregnancy by 4bpm from 146 to 142bpm (p < .0001) while FHRSD and coupling increased (6.7 to 7.8 and .49 to .56, respectively (p < .05) (see Table 2). These findings did not vary by sex.
Associations Between Negative Mood and Maternal Biology
Based on Spearman's rank-order correlation tests, there were no significant associations between negative mood and any of the maternal biological variables (all p-values >.20; see Supplemental Table 1).
Exploratory Variables: Associations Between Maternal Biological Variables and Fetal Measures
In Spearman's rank-order correlation tests of associations between log CRH, CRP, IL6, ABP, HR physical activity and each fetal outcome, the following exploratory variables met criterion (p < .1): 1st and 2nd session physical activity, and 1st session systolic and diastolic ABP. As these blood pressure variables are highly correlated, diastolic ABP was added, along with physical activity, to models predicting fetal measures.
FHR: Associations With Maternal Negative Mood and Physical Activity
There were no main effects for maternal negative mood, cortisol, diastolic ABP, or physical activity in relation to FHR. However, there were significant interactions between negative mood and physical activity, respectively, and fetal sex (all p ≤ .05). For males, greater maternal 1st and 2nd session negative mood and 2nd session daily physical activity were associated with lower overall FHR (See Table 3, models 1–4). Specifically, as found in two different HLM models, for every unit increase in 1st and 2nd session negative mood, males showed 5.05 and 2.94 overall lower bpm FHR, respectively (see Fig. 2). For every unit increase in 2nd session maternal activity, males showed 2.95 bpm lower FHR (See Fig. 3). In relation to greater 1st session physical activity there was an interaction with sex (p < .01), though this one showing effects in the rate of change in FHR, and in females. Specifically, for females, greater 1st session maternal activity was associated with a flatter slope and less of a decrease in FHR across gestation (See Table 3, model 2). Results from models with 1st and 2nd session cortisol and 1st session negative mood showed no effects for cortisol. However, the results for negative mood were consistent with the others findings: higher negative mood was associated with lower FHR in males (data not shown).
Table 3. Summary of Results From HLM Analyses: Fetal Heart Rate1.
Intercept | Slope | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
Main Effect | Interaction | Est. by Sex | Main Effect | Interaction | Est. by Sex | ||||||
|
|
|
|
|
|
||||||
Model Variables | F Value | β | F Value | Sex | β | F Value | β | F Value | Sex | β | |
1 | Negative Mood 1st Session | 1.23 | −1.92 | 4.16* | F | 1.21 | 1.27 | −.25 | .00 | F | −.26 |
M*** | −5.05 | M | −.23 | ||||||||
2 | Negative Mood 1st Session | .76 | −1.43 | 4.99* | F | 1.99 | .44 | −.14 | .09 | F | −.08 |
M*** | −4.84 | M | −.21 | ||||||||
Physical Activity 1st Session | .07 | .40 | 4.19* | Fa | 2.63 | 1.80 | .16 | 7.22** | F** | .49 | |
M | −1.83 | M | −.16 | ||||||||
3 | Negative Mood 2nd Session | .00 | −.02 | 6.38* | F | 2.90 | .00 | −.01 | 1.49 | F | −.01 |
M** | −2.94 | M | .18 | ||||||||
4 | Negative Mood 2nd Session | .05 | −.26 | 6.77* | F | 2.66 | .04 | −.03 | 1.40 | F | .15 |
M*** | −3.18 | M | −.22 | ||||||||
Physical Activity 2nd Session | 1.44 | −.88 | 6.34* | F | 1.18 | .39 | .07 | .14 | F | .12 | |
M** | −2.95 | M | .03 |
All models controlled for maternal age, pre-pregnancy BMI, and pregnancy complications, and are significant at a Likelihood-ratio test of p < .001.
p < .10.
p < .05.
p < .01.
p < .001.
Figure 2.
1st session maternal negative mood interacts with fetal sex to predict fetal heart rate level across gestation (Low Negative = 25th percentile and below; High Negative = 75th percentile and above).
Figure 3.
2nd session maternal physical activity interacts with fetal sex to predict fetal heart rate level across gestation (Low Activity = 25th percentile and below; High Activity = 75th percentile and above).
FHRSD: Associations With Maternal Cortisol
For FHRSD, there were no main effects for maternal negative mood, diastolic ABP, or physical activity. Analyses did show a main effect of cortisol such that the higher the 2nd session cortisol, the greater the increase in FHRSD across gestation (Table 4, model 1). In a model also including 2nd session negative mood, cortisol showed the same association (Table 4, model 2, and Fig. 4).
Table 4. Summary of Results From HLM Analyses: Fetal Heart Rate Standard Deviation1.
Intercept | Slope | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
Main Effect | Interaction | Est.by Sex | Main Effect | Interaction | Est.by Sex | ||||||
|
|
|
|
|
|
||||||
Model Variables | F Value | β | F Value | Sex | β | F Value | β | F Value | Sex | β | |
1 | Cortisol 2nd Session | .78 | .64 | 2.86a | F | 1.40a | 4.20* | .22 | .20 | F | .17 |
M | −.12 | Ma | .26 | ||||||||
2 | Negative Mood 2nd Session | .00 | −.01 | 1.69 | F | −.57 | .09 | −.03 | .75 | F | −.10 |
Ma | .55 | M | .05 | ||||||||
Cortisol 2nd Session | .82 | .64 | 3.35a | F | 1.46* | 3.97* | .21 | .18 | F | .16 | |
M | −.18 | Ma | .25 |
All models controlled for maternal age, pre-pregnancy BMI, and pregnancy complications, and are significant at a Likelihood-ratio test of p < .001.
p < .10.
p < .05.
Figure 4.
2nd session maternal cortisol predicts the change in FHRV (SD) across gestation (Low Cortisol = 25th percentile and below; High Cortisol = 75th percentile and above). Contrast tests indicated that for the highest quartile value of maternal cortisol (visualized in figure 4), the FHRSD slope was significantly different from zero (p < .01), though it was not for the lowest value.
Coupling: Associations With Maternal Negative Mood, Cortisol, and Diastolic ABP
Maternal negative mood, cortisol, and diastolic ABP were associated with differences in fetal coupling; there were no significant associations with physical activity. As can be seen in Table 5, the higher 1st session negative mood, the higher the level of fetal coupling across gestation (p ≤ .01). Specifically, based on results from three different models (models 1, 3, and 4), for every unit increase in 1st session negative mood, there was .09 or .11 increase, respectively, in the average level of coupling across gestation. Moreover, there was a significant interaction between negative mood and fetal sex such that in relation to negative mood, females showed greater average levels of coupling.
Table 5. Summary of Results From HLM Analyses: Fetal Coupling1.
Intercept | Slope | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Main Effect | Interaction | Est. by Sex | Main Effect | Interaction | Est. by Sex | ||||||
|
|
|
|
|
|
||||||
Model Variables | F Value | β | F Value | Sex | β | F Value | β | F Value | Sex | β | |
1 | Negative Mood 1st Session | 7.22** | .09 | 9.53** | F** | .19 | 2.32 | .01 | .08 | F | .01 |
M | −.01 | M | .01 | ||||||||
2 | Cortisol 1st Session | 3.63 | .03 | 1.42 | F | .01 | 8.20** | −.01 | 5.14* | F | −.01 |
Ma | .05 | M** | −.02 | ||||||||
3 | Negative Mood 1st Session | 9.21** | .11 | 5.21* | F* | .22 | .60 | .01 | .21 | F | .01 |
M | .03 | M | .00 | ||||||||
Cortisol 1st Session | 3.32 | .03 | 2.22 | F | .00 | 9.20** | −.02 | .17 | F | −.01 | |
M* | .05 | M** | −.02 | ||||||||
4 | Negative Mood 1st Session | 12.43*** | .11 | 15.93*** | F*** | .23 | 3.87a | .02 | .52 | F | .02 |
M | −.01 | M | .01 | ||||||||
Diastolic BP 1st Session | 6.43** | .00 | 4.13* | F** | −.01 | .02 | .00 | 1.53 | F | .00 | |
M | .00 | M | .00 |
All models controlled for maternal age, pre-pregnancy BMI, and pregnancy complications, and are significant at a Likelihood-ratio test of p < .001.
p < .10.
p < .05.
p < .01.
p < .001.
Also shown in two models (2 and 3) in Table 5, higher 1st session maternal cortisol was associated with less of an increase in coupling levels over gestation (p < .01) and there was a significant interaction with sex (p < .05) (model 2) such that this finding was more significant in males. In addition, in model 3, results show a significant positive association between 1st session cortisol and the average level of coupling in males, but not females (Table 5 and Fig. 5). Finally, for 1st session diastolic ABP, higher levels were associated with lower coupling across gestation (p < .01), especially for females (model 4).
Figure 5.
1st session maternal cortisol interacts with fetal sex to predict fetal coupling across gestation (Low Cortisol = 25th percentile and below; High Cortisol = 75th percentile and above). Contrast tests show that for the lowest quartile value of maternal cortisol, the coupling slope was significantly different from zero (p < .01), though it was not for the highest value.
Discussion
Similar to established neurobehavioral trajectories for early infancy (Diamond, 1995), our assessment of fetal outcomes showed development in the expected directions from mid to late pregnancy, specifically a decrease in FHR and increases in FHRSD and coupling (DiPietro, 2005; Dipietro et al., 2004). In this context of expectable development, maternal distress was associated with subtle variations in fetal measures and their rate of change. These results provide proximal evidence for the putative in utero shaping of children's futures in relation to maternal psychobiological status—a common premise of developmental research that is rarely tested directly. There were effects of exposure to maternal distress for both earlier in pregnancy (the 1st session) and from mid to later (the 2nd session), which were observed for fetal neurobehavioral trajectories across mid (the 2nd session) to late (the 3rd session) periods of gestation. Fetal sex was a significant factor. Results for male fetuses most often suggested that maternal distress lead to accelerated development, while for females, the effects differed, some showing acceleration, others a subtle deviation from what is expected and thus a potential mark of a risk phenotype. Finally, consistent with other research (Davis & Sandman, 2012; Huizink et al., 2003), despite the use of novel, ecologically valid, ambulatory assessments, we did not find any associations between biological and psychological indices of maternal distress (negative mood), and therefore, no biological mediation of the negative mood effects on fetal measures. However, maternal cortisol, as well as diastolic blood pressure and physical activity, showed some independent associations. The results add support to a role for maternal HPA axis and vascular regulation affecting fetal development and point to the challenges in identifying the physiological pathways by which maternal prenatal psychosocial experience is related to child outcomes.
The two a priori hypothesized variables, maternal negative mood and cortisol, showed associations with fetal measures moderated by sex. For male fetuses, a higher level of maternal negative mood, ascertained from multiple ambulatory assessments throughout a 24 hr period from earlier (1st session) as well as middle (2nd session) pregnancy was related to lower FHR across gestation, a mark of accelerated development. Finally, greater negative mood earlier in pregnancy (1st session) was associated with higher levels of fetal coupling across time points—indicative of accelerated development given the normative trajectory for this fetal outcome. In addition to this main effect, there was a sex effect such that this result was largely driven by findings with females.
Rather than maternal negative mood altering fetal development in ways that primarily mark a risk phenotype (lower levels of expected fetal measures as we had predicted and others have found (Allister et al., 2001; Dieter et al., 2008; DiPietro et al., 1996a,b; Pressman et al., 1998)), frequently the data indicated that maternal distress was associated with accelerated fetal development (seen fairly consistently in males, see below for discussion on sex differences). These results can be interpreted in two ways, which are not mutually exclusive.
Mild to moderate levels of psychological distress may enhance fetal maturation based on the opportunity to sample additional stimulation resulting from women's psychologically induced physiological reactivity and variability (DiPietro, Novak, Costigan, Atella, & Reusing, 2006). Throughout gestation, fetal development may be shaped by these alterations in women's biology (e.g., auditory stimuli from the cardiovascular and gastrointestinal systems, somatosensory activation from changes in breathing rate, and thermodynamics) with heightened opportunities for conditioning enhancing neural development (Costigan et al., 2008; DiPietro et al., 2003, 2008; Monk et al., 2000, 2004; Novak, 2004). Higher maternal distress has been associated with advanced postnatal motor and cognitive development (DiPietro, 2004, 2010). It also has been associated with greater fetal coupling (DiPietro et al., 2010), as shown in the current study, which in turn, predicts more mature neural integration at birth (DiPietro et al., 2010). These findings are in line with an animal model showing that in pregnant rats exposure to mild stress is associated with offspring having enhanced learning abilities (Fujioka et al., 2001). Previously, we reported maternal prenatal distress, including frank psychiatric symptoms of mood disorders, was associated with greater FHR reactivity when women underwent a laboratory stressor, and interpreted the findings using a risk-model as indicating a potential marker for future stress-based psychopathology (Monk et al., 2000, 2004, 2010). Possibly these results instead index accelerated development and more mature ANS control of the cardiac system.
These results also are in line with a theoretical model suggesting that maternal distress facilitates accelerated development to shape neurobehavioral systems to reduce time in the adverse in utero environment and promote survival in the non-optimal postnatal one to come (Glover, 2011; McLean et al., 1995; Pike, 2005). In this perspective, whether this precocity is beneficial to long-term health trajectories depends on the correspondence or “fit” between the neurobiological profile established in utero and the demands of the postnatal world (Ellis, 2011; Frankenhuis & Del Giudice, 2012; Glover, 2011; Sandman et al., 2012). Alternatively, another view supported by recent data suggests that there is a detrimental trade off to long-term health of early accelerated development (Sandman et al., 2013).
The other a priori predictor variable, higher cortisol, based on AUC of daily samples, was associated with an accelerated rate of change over gestation in fetal parameters. Specifically, higher 2nd session cortisol was associated with a steeper increase in FHRSD over gestation. In addition, higher 1st session maternal cortisol was associated with a slower increase in coupling over time, and this tended to be more true for males. However, this relative elevation in cortisol also showed a sex finding such that higher cortisol was associated with greater couplings in males. Taken together these coupling findings related to maternal cortisol suggest accelerated development: males may be at higher levels sooner and increase less as gestation goes on.
Maternal HPA axis regulation is the distress-linked biological parameter most consistently associated with differences in fetal, infant, and child outcomes. The majority of findings relate exposure to elevated maternal cortisol to a neurobehavioral risk profile including greater stress reactivity at birth and infant fussiness in the first months of life (Davis, Waffarn, & Sandman, 2010; de Weerth, van Hees, & Buitelaar, 2003; Werner et al., 2013). In the few fetal studies considering maternal cortisol as a possible influence on fetal development, associations were found between concurrently tested elevations and greater movement at 32–36 gestational weeks (DiPietro et al., 2009) and higher overall FHR at 36–38 weeks (Monk et al., 2004). Using a longitudinal study design, Glynn and Sandman (2012) showed lower cortisol early in pregnancy was associated with precocious development indexed by mounting a motor response to a vibro acoustic stimulus (Glynn & Sandman, 2012). To our knowledge, our current study is the only report showing higher maternal cortisol associated with indicators of accelerated fetal development, though it is consistent with evolutionary perspectives on maternal distress effects (see below), as well as the biological role cortisol plays in regulating fetal development. Glucocorticoids are critical to the maturation of the human fetal lungs (Ballard & Ballard, 1974), CNS, and brain (Uno et al., 1994). Synthetic glucocorticoids such as dexamethasone have provided a model for the effects of maternal cortisol levels on offspring development, showing prenatal exposure to elevated levels of dexamethasone alters the normal developmental trajectory of CNS and brain (Uno et al., 1990) at multiple levels, including accelerated trajectory of neuronal maturation (Slotkin et al., 1992).
Two other maternal variables that showed associations with fetal measures were diastolic blood pressure and physical activity. Consistent with our original hypothesis, higher diastolic blood pressure in early pregnancy (1st session) was associated with lower levels of coupling, particularly for females. Greater physical activity early in pregnancy (1st session) was associated with higher FHR across gestation and a less of a decrease in slope in females whereas in mid pregnancy (2nd session) it was associated with lower overall FHR levels in males. Physical activity as an independent predictor of fetal measures was unexpected, though the results are consistent with those showing that physical exercise during pregnancy influences fetal ANS development (Gustafson, May, Yeh, Million, & Allen, 2012; May, Glaros, Yeh, Clapp, & Gustafson, 2010; May, Suminski, Langaker, Yeh, & Gustafson, 2012), and point to yet another lifestyle characteristic through which women may shape fetal development. However, our index of physical activity was not very rigorous; future research exploring this maternal factor for fetal development should use other approaches, such as more objective systems using an accelerometer worn on the wrist (Trost, Loprinzi, Moore, & Pfeiffer, 2011; Ward, Evenson, Vaughn, Rodgers, & Troiano, 2005).
Fetal sex significantly moderated the associations between maternal factors and the range of fetal measures. In the context of greater maternal negative mood, elevated cortisol, more physical activity, and higher maternal diastolic blood pressure, female fetuses showed deviations from expected behavior (slower decrease in FHR, less coupling) as well as accelerated development (greater coupling). Under similar conditions, male fetuses evidenced accelerated development (decrease in FHR, slower increase in coupling in the context of a positive association between cortisol and overall coupling levels). Clifton (Clifton, 2010) has proposed that sex differences in the function and structure of the placenta may play a role in sex differences in maternal distress-related fetal and child outcomes. In Clifton's view, female fetuses make multiple adaptations in placental gene and protein expression in response to intrauterine adversity (e.g., maternal asthma and preeclampsia). Similar to Glynn et al. (2012), our results suggest that the female fetus is variously responsive to signals from the prenatal context. For males, Clifton suggests they have a “minimalist” approach and show fewer signs of adapting to their context, which may put them at risk in the future, consistent with the higher levels of neurodevelopmental disorders seen in male children (Clifton, 2010; Clifton, Stark, Osei-Kumah, & Hodyl, 2012). We found that male fetuses did alter their development in the face of maternal distress, though with a uniform response of accelerated development.
The questions of when distress exposure has effects on shaping which outcomes are key issues concerning two changing systems over the course of pregnancy: fetal development and maternal psychobiology. Some studies show effects of late pregnancy distress (Ellman et al., 2008; Huizink et al., 2003), many others find effects early on, these largely consistent with the risk phenotype model (Davis & Sandman, 2010; Ellman et al., 2008; Davis & Sandman, 2010; King & Laplante, 2005; Laplante et al., 2008). In this report, maternal factors assessed at 13–16 (1st session) and at 24–27 weeks (2nd session) were associated with variation in fetal behavior. Neuronal migration peaks between gestational weeks 12–20 and the architectural framework and functional capacities of the major neurotransmitter systems are established early in gestation. Factors that alter the neurotransmitter physiology, such as glucocorticoids or variation in oxygenation, may affect the development of neural circuits and neurotransmitter systems in subtle though significant ways that are as yet poorly understood (Tau & Peterson, 2010). Clearly, future studies, with more fine grained time frames, are needed to begin to characterize the specificity of timing effects.
Despite the inclusion of multiple potential biological effectors of maternal distress reflecting different physiological systems—cardiovascular, HPA, immune, and ecologically valid daily sampling, we did not find associations between maternal negative mood and these biological variables, and few associations with fetal variables. Similar to other research (Davis & Sandman, 2012; Huizink et al., 2003; Ponirakis et al., 1998; Rieger et al., 2004), our results do not identify a biological, mediating pathway by which maternal psychological distress affects the fetus. Instead, results underscore the need to consider a complex series of transmissions, e.g., maternal anxiety affects placental gene expression (O'Donnell et al., 2012), which, in turn, influences fetal exposure to maternal stress hormones, as well as indirect effects, e.g., maternal distress is a marker variable for nutrition, which influences the fetus (Monk, Georgieff, & Osterholm, 2012a). EMA is a sensitive method of assessing perceived psychological distress (Entringer et al., 2011) though within subject, event-related approaches (Gies-brecht, Campbell, Letourneau, & Kaplan, 2013) or those tracking mood-based differences in biological trajectories over gestation (Kane, Dunkel Schetter, Glynn, Hobel, & Sandman, 2014), and not using a composite value such as ours, may be needed to characterize the co-variation of mood and biology, and to relate them to fetal development. Finally, though we modeled our EMA approach to mood dysregulation in adolescents on similar studies with this age group (Adam, 2006; DeSantis et al., 2007), and used an empirically validated method to produce a composite score that we labeled negative mood (consisting of angry, frustrated, irritated, and stressed), this distress index did not target depression and anxiety, which may have contributed to our null findings.
Conclusion
There are developmental origins to almost all forms of psychopathology (Cicchetti & Rogosch, 1996; Sroufe & Rutter, 1984), with strong evidence supporting the role of neurodevelopmental pathways (Insel, 2014; Insel & Wang, 2010). Increasingly, maternal prenatal distress is accepted as contributing to these neuro-behavioral outcomes based on extensive data showing associations between it and at-risk infant, child, and adult mental health profiles (Beydoun & Saftlas, 2008). Here we show evidence for the premise underlying these prenatal programming studies: proximal associations between maternal distress and variation in fetal development. However, our measures suggesting relative decrements as well as acceleration in expected fetal outcomes, and significant moderation by sex, indicate that this relatively brief neurodevelopmental period—in utero—encompasses heterogeneous pathways and complex processes to arrive at the individual differences present at birth.
Supplementary Material
Acknowledgments
Contract grant sponsor: National Institute of Mental Health
Contract grant number: MH077144-01A2
The authors wish to thank the young women who participated in this study, our top-notch research assistants, Laura Kurzius, Willa Marquis, and Sophie Foss, for dedicated help with participant engagement and all of the data collection. We gratefully acknowledge three anonymous reviewers for their helpful comments on a previous draft. This research was supported by the National Institute of Mental Health: MH077144-01A2 to CM.
Footnotes
Following Hoffman & Hatch (Hoffman & Hatch, 1996), we use the term “distress” to describe negative emotional states that may result from the perception of challenging, difficult, “stressful” experiences.
Supporting Information: Additional supporting information may be found in the online version of this article.
Conflicts of interest: The authors declare that there are no conflicts of interest.
References
- Adam EK. Transactions among adolescent trait and state emotion and diurnal and momentary cortisol activity in naturalistic settings. Psychoneuroendocrinology. 2006;31(5):664–679. doi: 10.1016/j.psyneuen.2006.01.010. [DOI] [PubMed] [Google Scholar]
- Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34(10):1423–1436. doi: 10.1016/j.psyneuen.2009.06.011. [DOI] [PubMed] [Google Scholar]
- Allister L, Lester BM, Carr S, Liu E. The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation. Developmental Neuropsychology. 2001;20(3):639–651. doi: 10.1207/S15326942DN2003_6. [DOI] [PubMed] [Google Scholar]
- Baibazarova E, van de Beek C, Cohen-Kettenis PT, Buitelaar J, Shelton KH, van Goozen SH. Influence of prenatal maternal stress, maternal plasma cortisol and cortisol in the amniotic fluid on birth outcomes and child temperament at 3 months. Psychoneuroendocrinology. 2013;38(6):907–915. doi: 10.1016/j.psyneuen.2012.09.015. [DOI] [PubMed] [Google Scholar]
- Ballard PL, Ballard RA. Cytoplasmic receptor for glucocorticoids in lung of the human fetus and neonate. Journal of Clinical Investigation. 1974;53(2):477. doi: 10.1172/JCI107581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, et al. Nestler EJ. Early life programming and neurodevelopmental disorders. Biological Psychiatry. 2010;68(4):314–319. doi: 10.1016/j.biopsych.2010.05.028. doi:S0006-3223(10)00527-5 [pii]10.1016/j.biopsych.2010.05.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baser I, Johnson TR, Paine LL. Coupling of fetal movement and fetal heart rate accelerations as an indicator of fetal health. Obstetrics Gynecology. 1992;80(1):62–66. [PubMed] [Google Scholar]
- Beevers G, Lip GY, O'Brien E. ABC of hypertension: Blood pressure measurement. Part II-conventional sphygmomanometry: Technique of auscultatory blood pressure measurement. BMJ (Clinical research ed) 2001;322(7293):1043–1047. doi: 10.1136/bmj.322.7293.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bendat JS, Piersol AG. Random data analysis and measurement procedures. Measurement Science and Technology. 2000;11(12):1825. [Google Scholar]
- Besinger RE, Johnson TR. Doppler recording of fetal movement: Clinical correlation with real-time ultrasound. Obstetrics Gynecology. 1989;74(2):277–280. [PubMed] [Google Scholar]
- Beydoun H, Saftlas AF. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: A review of recent evidence. Paediatric Perinatal Epidemiology. 2008;22(5):438–466. doi: 10.1111/j.1365-3016.2008.00951.x. doi:PPE951 [pii]10.1111/j.1365-3016.2008.00951.x. [DOI] [PubMed] [Google Scholar]
- Bilbo SD, Schwarz JM. The immune system and developmental programming of brain and behavior. Frontiers in neuroendocrinology. 2012;33(3):267–286. doi: 10.1016/j.yfrne.2012.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boksa P. Effects of prenatal infection on brain development and behavior: A review of findings from animal models. Brain Behavior and Immunity. 2010;24(6):881–897. doi: 10.1016/j.bbi.2010.03.005. doi:S0889-1591(10)00058-9 [pii]10.1016/j.bbi.2010.03.005. [DOI] [PubMed] [Google Scholar]
- Bornstein MH, DiPietro JA, Hahn CS, Painter K, Haynes OM, Costigan KA. Prenatal cardiac function and postnatal cognitive development: An exploratory study. Infancy. 2002;3(4):475–494. [Google Scholar]
- Buss C, Davis EP, Hobel CJ, Sandman CA. Maternal pregnancy-specific anxiety is associated with child executive function at 6–9 years age. Stress. 2011;14(6):665–676. doi: 10.3109/10253890.2011.623250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buss C, Davis EP, Shahbaba B, Pruessner JC, Head K, Sandman CA. Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problems. Proceedings of the National Academy of Sciences. 2012;109(20):E1312–E1319. doi: 10.1073/pnas.1201295109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caldwell CH, Antonucci TC. Childbearing during adolescence: Mental health risks and opportunities. Health Risks and Developmental Transitions During Adolescence. 1997;18:220–245. [Google Scholar]
- Chan EC, Smith R, Lewin T, Brinsmead MW, Zhang HP, Cubis J, et al. Hurt D. Plasma cortico-tropin-releasing hormone, β-endorphin and cortisol interrelationships during human pregnancy. Acta Endocrinologica. 1993;128(4):339–344. doi: 10.1530/acta.0.1280339. [DOI] [PubMed] [Google Scholar]
- Charil A, Laplante DP, Vaillancourt C, King S. Prenatal stress and brain development. Brain Research Reviews. 2010;65:56–79. doi: 10.1016/j.brainresrev.2010.06.002. [DOI] [PubMed] [Google Scholar]
- Cicchetti D, Rogosch FA. Equifinality and multifinality in developmental psychopathology. Development and Psychopathology. 1996;8(04):597–600. [Google Scholar]
- Clifton VL. Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31:S33–S39. doi: 10.1016/j.placenta.2009.11.010. doi:S0143-4004(09)00373-7 [pii]10.1016/j.placenta.2009.11.010. [DOI] [PubMed] [Google Scholar]
- Clifton VL, Stark MJ, Osei-Kumah A, Hodyl NA. Review: The feto-placental unit, pregnancy pathology and impact on long term maternal health. Placenta. 2012;33:S37–S41. doi: 10.1016/j.placenta.2011.11.005. doi:S0143-4004(11)00537-6 [pii]10.1016/j.placenta.2011.11.005. [DOI] [PubMed] [Google Scholar]
- Conover WJ. Practical Nonparametric Statistics. New York: John Wiley & Sons; 1971. pp. 295–301. [Google Scholar]
- Dalton KJ, Dawes GS, Patrick JE. The autonomic nervous system and fetal heart rate variability. American Journal of Obstetrics and Gynecology. 1983;146(4):456. doi: 10.1016/0002-9378(83)90828-1. [DOI] [PubMed] [Google Scholar]
- Davis EP, Glynn LM, Schetter CD, Hobel C, Chicz-Demet A, Sandman CA. Prenatal exposure to maternal depression and cortisol influences infant temperament. Journal of American Academy of Child Adolescent Psychiatry. 2007;46(6):737–746. doi: 10.1097/chi.0b013e318047b775. [DOI] [PubMed] [Google Scholar]
- Davis EP, Glynn LM, Waffarn F, Sandman CA. Prenatal maternal stress programs infant stress regulation. Journal of Child Psychology and Psychiatry. 2011;52(2):119–129. doi: 10.1111/j.1469-7610.2010.02314.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis EP, Sandman CA. The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Development. 2010;81(1):131–148. doi: 10.1111/j.1467-8624.2009.01385.x. doi:CDEV1385 [pii]10.1111/j.1467-8624.2009.01385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis EP, Sandman CA. Prenatal psychobiological predictors of anxiety risk in preadolescent children. Psychoneuroendocrinology. 2012 doi: 10.1016/j.psyneuen.2011.12.016. doi:S0306-4530(11)00371-4 [pii]10.1016/j.psyneuen.2011.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis EP, Waffarn F, Sandman CA. Prenatal treatment with glucocorticoids sensitizes the hpa axis response to stress among full-term infants. Developmental Psychobiology. 2011;53(2):175–183. doi: 10.1002/dev.20510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Weerth C, van Hees Y, Buitelaar JK. Prenatal maternal cortisol levels and infant behavior during the first 5 months. Early Human Development. 2003;74(2):139–151. doi: 10.1016/s0378-3782(03)00088-4. [DOI] [PubMed] [Google Scholar]
- DeSantis AS, Adam EK, Doane LD, Mineka S, Zinbarg RE, Craske MG. Racial/ethnic differences in cortisol diurnal rhythms in a community sample of adolescents. Journal of Adolescent Health. 2007;41(1):3–13. doi: 10.1016/j.jadohealth.2007.03.006. [DOI] [PubMed] [Google Scholar]
- Dieter JNI, Emory EK, Johnson KC, Raynor BD. Maternal depression and anxiety effects on the human fetus: Preliminary findings and clinical implications. Infant Mental Health Journal. 2008a;29(5):420–441. doi: 10.1002/imhj.20192. [DOI] [PubMed] [Google Scholar]
- DiPietro JA. The role of prenatal stress in child development. Current Directions in Psychological Science. 2004;13(2):71–74. [Google Scholar]
- DiPietro JA. Neurobehavioral assessment before birth. Mental Retardation and Developmental Disabilities Research Review. 2005;11(1):4–13. doi: 10.1002/mrdd.20047. [DOI] [PubMed] [Google Scholar]
- Dipietro JA. Maternal stress in pregnancy: considerations for fetal development. Journal of Adolescent Health. 2012;51(2):S3–S8. doi: 10.1016/j.jadohealth.2012.04.008. doi:S1054-139X(12)00170-X [pii]10.1016/j.jadohealth.2012.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DiPietro JA, Bornstein MH, Hahn CS, Costigan K, Achy-Brou A. Fetal heart rate and variability: Stability and prediction to developmental outcomes in early childhood. Child Development. 2007;78(6):1788–1798. doi: 10.1111/j.1467-8624.2007.01099.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DiPietro JA, Caulfield L, Costigan KA, Merialdi M, Nguyen RH, Zavaleta N, Gurewitsch ED. Fetal neurobehavioral development: A tale of two cities. Developmental Psychology. 2004b;40(3):445–456. doi: 10.1037/0012-1649.40.3.445. [DOI] [PubMed] [Google Scholar]
- DiPietro JA, Costigan KA, Gurewitsch ED. Fetal response to induced maternal stress. Early Human Development. 2003;74(2):125–138. doi: 10.1016/j.earlhumdev.2003.07.001. [DOI] [PubMed] [Google Scholar]
- DiPietro JA, Costigan KA, Nelson P, Gurewitsch ED, Laudenslager ML. Fetal responses to induced maternal relaxation during pregnancy. Biological Psychology. 2008b;77(1):11–19. doi: 10.1016/j.biopsycho.2007.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DiPietro JA, Costigan KA, Pressman EK. Fetal movement detection: Comparison of the Toitu actograph with ultrasound from 20 weeks gestation. Journal of Maternal Fetal Medicine. 1999;8(6):237–242. doi: 10.1002/(SICI)1520-6661(199911/12)8:6<237∷AID-MFM1>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
- DiPietro JA, Costigan KA, Pressman EK, Doussard-Roosevelt JA. Antenatal origins of individual differences in heart rate. Developmental Psychobiology. 2000;37(4):221–228. doi: 10.1002/1098-2302(2000)37:4<221::aid-dev2>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- DiPietro JA, Ghera MM, Costigan KA. Prenatal origins of temperamental reactivity in early infancy. Early Human Development. 2008a;84(9):569–575. doi: 10.1016/j.earlhumdev.2008.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DiPietro JA, Hodgson DM, Costigan KA, Hilton SC. Fetal neurobehavioral development. Child Development. 1996c;67:2553–2567. [PubMed] [Google Scholar]
- DiPietro JA, Hodgson DM, Costigan KA, Johnson TRB. Fetal antecedents of infant temperament. Child Development. 1996a;67:2568–2583. [PubMed] [Google Scholar]
- DiPietro JA, Hodgson KA, Costigan SC, Johnson TRB. Developmental of fetal movement-fetal heart rate coupling from 20 weeks through term. Early Human Development. 1996b;44:139–151. doi: 10.1016/0378-3782(95)01704-6. [DOI] [PubMed] [Google Scholar]
- Dipietro JA, Irizarry RA, Costigan KA, Gurewitsch ED. The psychophysiology of the maternal-fetal relationship. Psychophysiology. 2004a;41(4):510–520. doi: 10.1111/j.1469-8986.2004.00187.x. [DOI] [PubMed] [Google Scholar]
- Dipietro JA, Irizarry RA, Hawkins M, Costigan KA, Pressman EK. Cross-correlation of fetal cardiac and somatic activity as an indicator of antenatal neural development. American Journal of Obstetrics and Gynecology. 2001;185(6):1421–1428. doi: 10.1067/mob.2001.119108. [DOI] [PubMed] [Google Scholar]
- DiPietro JA, Kivlighan KT, Costigan KA, Laudenslager ML. Fetal motor activity and maternal cortisol. Developmental Psychobiology. 2009;51(6):505–512. doi: 10.1002/dev.20389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DiPietro JA, Kivlighan KT, Costigan KA, Rubin SE, Shiffler DE, Henderson JL, Pillion JP. Prenatal antecedents of newborn neurological maturation. Child Development. 2010;81(1):115–130. doi: 10.1111/j.1467-8624.2009.01384.x. doi:CDEV1384 [pii]10.1111/j.1467-8624.2009.01384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DiPietro JA, Novak MF, Costigan KA, Atella LD, Reusing SP. Maternal psychological distress during pregnancy in relation to child development at age two. Child Development. 2006;77(3):573–587. doi: 10.1111/j.1467-8624.2006.00891.x. [DOI] [PubMed] [Google Scholar]
- Dobbing J, Smart JL. Vulnerability of developing brain and behavior. British Medical Bulletin. 1974;20:164–168. doi: 10.1093/oxfordjournals.bmb.a071188. [DOI] [PubMed] [Google Scholar]
- Ellis BJ, Boyce WT, Belsky J, Bakermans-Kranenburg MJ, Van IJzendoorn MH. Differential susceptibility to the environment: An evolutionary-neuro-developmental theory. Development and Psychopathology. 2011;23(1):7–28. doi: 10.1017/S0954579410000611. [DOI] [PubMed] [Google Scholar]
- Ellman LM, Schetter CD, Hobel CJ, Chicz-Demet A, Glynn LM, Sandman CA. Timing of fetal exposure to stress hormones: Effects on newborn physical and neuromuscular maturation. Developmental Psychobiology. 2008;50(3):232–241. doi: 10.1002/dev.20293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Entringer S, Buss C, Andersen J, Chicz-DeMet A, Wadhwa PD. Ecological momentary assessment of maternal cortisol profiles over a multiple-day period predicts the length of human gestation. Psychosomatic Medicine. 2011;73(6):469–474. doi: 10.1097/PSY.0b013e31821fbf9a. doi:PSY.0b013e31821fbf9a [pii]10.1097/PSY.0b013e31821fbf9a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Entringer S, Epel ES, Lin J, Buss C, Shahbaba B, Blackburn EH, et al. Wadhwa PD. Maternal psychosocial stress during pregnancy is associated with newborn leukocyte telomere length. American Journal of Obstetrics and Gynecology. 2013;208(2):134–e1. doi: 10.1016/j.ajog.2012.11.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fekedulegn DB, Andrew ME, Burchfiel CM, Violanti JM, Hartley TA, Charles LE, Miller DB. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosomatic Medicine. 2007;69(7):651–659. doi: 10.1097/PSY.0b013e31814c405c. [DOI] [PubMed] [Google Scholar]
- Fencl MD, Stillman RJ, Cohen J, Tulchinsky D. Direct evidence of sudden rise in fetal corticoids late in human gestation. Nature. 1980;287:225–226. doi: 10.1038/287225a0. [DOI] [PubMed] [Google Scholar]
- Fink NS, Urech C, Berger CT, Hoesli I, Holzgreve W, Bitzer J, Alder J. Maternal laboratory stress influences fetal neurobehavior: Cortisol does not provide all answers. Journal of Maternal-Fetal and Neonatal Medicine. 2010;23(6):488–500. doi: 10.3109/14767050903300985. [DOI] [PubMed] [Google Scholar]
- Frankenhuis WE, Del Giudice M. When do adaptive developmental mechanisms yield maladaptive outcomes? Developmental psychology. 2012;48(3):628. doi: 10.1037/a0025629. [DOI] [PubMed] [Google Scholar]
- Freeman RK, Garite TJ, Nageotte MP, Miller LA. Fetal heart rate monitoring. Lippincott Williams & Wilkins; 2012. [Google Scholar]
- Fujioka T, Fujioka A, Tan N, Chowdhury G, Mouri H, Sakata Y, Nakamura S. Mild prenatal stress enhances learning performance in the non-adopted rat offspring. Neuroscience. 2001;103:301–307. doi: 10.1016/s0306-4522(00)00582-0. [DOI] [PubMed] [Google Scholar]
- Geisler FC, Kubiak T, Siewert K, Weber H. Cardiac vagal tone is associated with social engagement and self-regulation. Biological Psychology. 2013;93(2):279–286. doi: 10.1016/j.biopsycho.2013.02.013. [DOI] [PubMed] [Google Scholar]
- Giesbrecht GF, Campbell T, Letourneau N, Kaplan BJ. Advancing gestation does not attenuate biobehavioural coherence between psychological distress and cortisol. Biological Psychology. 2013;93(1):45–51. doi: 10.1016/j.biopsycho.2013.01.019. doi:S0301-0511(13)00032-X [pii]10.1016/j.biopsy-cho.2013.01.019. [DOI] [PubMed] [Google Scholar]
- Glover V. Annual Research Review: Prenatal stress and the origins of psychopathology: an evolutionary perspective. Journal of Child Psychology and Psychiatry. 2011;52(4):356–367. doi: 10.1111/j.1469-7610.2011.02371.x. [DOI] [PubMed] [Google Scholar]
- Glover V, O'Connor TG, O'Donnell K. Prenatal stress and the programming of the HPA axis. Neuroscience & Biobehavioral Reviews. 2010;35(1):17–22. doi: 10.1016/j.neubiorev.2009.11.008. [DOI] [PubMed] [Google Scholar]
- Gluckman PD, Hanson MA, Spencer HG. Predictive adaptive responses and human evolution. Trends in Ecology and Evolution. 2005;20:527–533. doi: 10.1016/j.tree.2005.08.001. [DOI] [PubMed] [Google Scholar]
- Glynn LM, Sandman CA. Sex moderates associations between prenatal glucocorticoid exposure and human fetal neurological development. Developmental Science. 2012;15(5):601–610. doi: 10.1111/j.1467-7687.2012.01159.x. [DOI] [PubMed] [Google Scholar]
- Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. Journal of Clinical Endocrinology and Metabolism. 1993;77(5):1174–1179. doi: 10.1210/jcem.77.5.8077309. [DOI] [PubMed] [Google Scholar]
- Gustafson KM, May LE, Yeh HW, Million SK, Allen JJ. Fetal cardiac autonomic control during breathing and non-breathing epochs: The effect of maternal exercise. Early Human Development. 2012;88(7):539–546. doi: 10.1016/j.earlhumdev.2011.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harville EW, Savitz DA, Dole N, Herring AH, Thorp JM. Stress questionnaires and stress biomarkers during pregnancy. Journal of Women's Health. 2009;18(9):1425–1433. doi: 10.1089/jwh.2008.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoffman S, Hatch MC. Stress, social support and pregnancy outcome: A reassessment based on recent research. Paediatric and Perinatal Epidemiology. 1996;10(4):380–405. doi: 10.1111/j.1365-3016.1996.tb00063.x. [DOI] [PubMed] [Google Scholar]
- Huizink AC, Robles de Medina PG, Mulder EJ, Visser GH, Buitelaar JK. Stress during pregnancy is associated with developmental outcome in infancy. Journal of Child Psychology and Psychiatry. 2003;44(6):810–818. doi: 10.1111/1469-7610.00166. [DOI] [PubMed] [Google Scholar]
- Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–193. doi: 10.1038/nature09552. [DOI] [PubMed] [Google Scholar]
- Insel TR. Mental disorders in childhood: Shifting the focus from behavioral symptoms to neurodevelopmental trajectories. Journal of the American Medical Association. 2014;311(17):1727–1728. doi: 10.1001/jama.2014.1193. [DOI] [PubMed] [Google Scholar]
- Insel TR, Wang PS. Rethinking mental illness. Journal of the American Medical Association. 2010;303(19):1970–1971. doi: 10.1001/jama.2010.555. doi:303/19/1970 [pii]10.1001/jama.2010.555. [DOI] [PubMed] [Google Scholar]
- Kaplan BJ, Giesbrecht GF, Leung BM, Field CJ, Dewey D, Bell RC, et al. Martin JW. The Alberta pregnancy outcomes and nutrition (APrON) cohort study: Rationale and methods. Maternal & Child Nutrition. 2014;10(1):44–60. doi: 10.1111/j.1740-8709.2012.00433.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kane HS, Dunkel Schetter C, Glynn LM, Hobel CJ, Sandman CA. Pregnancy anxiety and prenatal cortisol trajectories. Biological Psychology. 2014;100:13–19. doi: 10.1016/j.biopsycho.2014.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, et al. Mortensen PB. Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Archives of General Psychiatry. 2008;65(2):146–152. doi: 10.1001/archgenpsychiatry.2007.20. [DOI] [PubMed] [Google Scholar]
- King S, Laplante DP. The effects of prenatal maternal stress on children's cognitive development: Project Ice Storm. Stress. 2005;8(1):35–45. doi: 10.1080/10253890500108391. doi:UP61488770455R12 [pii]10.1080/10253890500108391. [DOI] [PubMed] [Google Scholar]
- Kovacs M, Krol RSM, Voti L. Early onset psychopathology and the risk for teenage pregnancy among clinically referred girls. Journal of the American Academy of Child & Adolescent Psychiatry. 1994;33(1):106–113. doi: 10.1097/00004583-199401000-00014. [DOI] [PubMed] [Google Scholar]
- Laplante DP, Brunet A, Schmitz N, Ciampi A, King S. Project Ice Storm: Prenatal maternal stress affects cognitive and linguistic functioning in 5 1/2-year-old children. J Am Acad Child Adolesc Psychiatry. 2008;47(9):1063–1072. doi: 10.1097/CHI.0b013e31817eec80. doi:10.1097/CHI.0b013e31817eec80S0890-8567(09)60082-9 [pii] [DOI] [PubMed] [Google Scholar]
- May LE, Glaros A, Yeh HW, Clapp JF3rd, Gustafson KM. Aerobic exercise during pregnancy influences fetal cardiac autonomic control of heart rate and heart rate variability. Early Human Development. 2010;86(4):213–217. doi: 10.1016/j.earlhumdev.2010.03.002. [DOI] [PubMed] [Google Scholar]
- May LE, Suminski RR, Langaker MD, Yeh HW, Gustafson KM. Regular maternal exercise dose and fetal heart outcome. Medicine and Science in Sports and Exercise. 2012;44(7):1252–1258. doi: 10.1249/MSS.0b013e318247b324. [DOI] [PubMed] [Google Scholar]
- Mendelson T, DiPietro JA, Costigan KA, Chen P, Henderson JL. Associations of maternal psychological factors with umbilical and uterine blood flow. Journal of Psychosomatic Obstetrics and Gynaecology. 2011;32(1):3–9. doi: 10.3109/0167482X2010.544427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nature Medicine. 1995;1(5):460–463. doi: 10.1038/nm0595-460. [DOI] [PubMed] [Google Scholar]
- Monk C, Fifer WP, Myers MM, Bagiella E, Duong JK, Chen IS, et al. Altincatal A. Effects of maternal breathing rate, psychiatric status, and cortisol on fetal heart rate. Developmental Psychobiology. 2010 doi: 10.1002/dev.20513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monk C, Fifer WP, Myers MM, Sloan RP, Trien L, Hurtado A. Maternal stress responses and anxiety during pregnancy: Effects on fetal heart rate. Developmental Psychobiology. 2000;36(1):67–77. [PubMed] [Google Scholar]
- Monk C, Fifer WP, Sloan RP, Myers MM, Trien L, Hurtado A. Maternal stress responses and anxiety during pregnancy: Effects on fetal heart rate. Developmental Psychobiology. 2000;36:67–77. [PubMed] [Google Scholar]
- Monk C, Georgieff MK, Osterholm EA. Research Review: Maternal prenatal distress and poor nutrition-mutually influencing risk factors affecting infant neurocognitive development. Journal of Child Psychology and Psychiatry. 2012a doi: 10.1111/jcpp.12000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monk C, Myers MM, Sloan RP, Ellman LM, Fifer WP. Effects of women's stress-elicited physiological activity and chronic anxiety on fetal heart rate. Journal of Developmental Behavior Pediatrics. 2003;24(1):32–38. doi: 10.1097/00004703-200302000-00008. [DOI] [PubMed] [Google Scholar]
- Monk C, Myers MM, Sloan RP, Werner L, Jeon J, Tager F, Fifer WP. Fetal heart rate reactivity differs by women's psychiatric status: An early marker for developmental risk? Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43(3):283–290. doi: 10.1097/00004583-200403000-00009. [DOI] [PubMed] [Google Scholar]
- Monk C, Newport DJ, Korotkin JH, Long Q, Knight B, Stowe ZN. Uterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medication. Biological Psychiatry. 2012b;72(6):483–490. doi: 10.1016/j.biopsych.2012.05.006. doi:S0006-3223(12)00421-0 [pii]10.1016/j.biopsych.2012.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. Journal of Neuroscience. 2008;28(36):9055–9065. doi: 10.1523/JNEUROSCI.1424-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novak MF. Fetal-maternal interactions: Prenatal psychobiological precursors to adaptive infant development. Current Topics in Developmental Biology. 2004;59:37–60. doi: 10.1016/S0070-2153(04)59002-6. [DOI] [PubMed] [Google Scholar]
- Obel C, Hedegaard M, Henriksen TB, Secher NJ, Olsen J. Psychological factors in pregnancy and mixed-handedness in the offspring. Developmental Medicine and Child Neurology. 2003;45(8):557–561. doi: 10.1017/s0012162203001014. [DOI] [PubMed] [Google Scholar]
- O'Connor TG, Heron J, Golding J, Beveridge M, Glover V. Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Brtish Journal of Psychiatry. 2002;180:502–508. doi: 10.1192/bjp.180.6.502. [DOI] [PubMed] [Google Scholar]
- O'Connor TG, Heron J, Golding J, Glover V. Maternal antenatal anxiety and behavioural/emotional problems in children: A test of a programming hypothesis. Journal of Child Psychology and Psychiatry. 2003;44(7):1025–1036. doi: 10.1111/1469-7610.00187. [DOI] [PubMed] [Google Scholar]
- O'Donnell KJ, Bugge Jensen A, Freeman L, Khalife N, O'Connor TG, Glover V. Maternal prenatal anxiety and downregulation of placental 11beta-H SD2. Psychoneuroendocrinology. 2012;37(6):818–826. doi: 10.1016/j.psyneuen.2011.09.014. doi:S0306-4530(11)00284-8 [pii]10.1016/j.psyneuen.2011.09.014. [DOI] [PubMed] [Google Scholar]
- Owen D, Andrews MH, Matthews SG. Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neuroscience Biobehavior Review. 2005;29(2):209–226. doi: 10.1016/j.neubiorev.2004.10.004. [DOI] [PubMed] [Google Scholar]
- Pike IL. Maternal stress and fetal responses: Evolutionary perspectives on preterm delivery. American Journal of Human Biology. 2005;17(1):55–65. doi: 10.1002/ajhb.20093. [DOI] [PubMed] [Google Scholar]
- Ponirakis A, Susman EJ, Stifter CA. Negative emotionality and cortisol during adolescent pregnancy and its effects on infant health and autonomic nervous system reactivity. Developmental psychobiology. 1998;33(2):163–174. [PubMed] [Google Scholar]
- Porges SW, Furman SA. The early development of the autonomic nervous system provides a neural platform for social behavior: A polyvagal perspective. Infant Child Development. 2011;20(1):106–118. doi: 10.1002/icd.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pressman EK, DiPietro JA, Costigan KA, Shupe AK, Johnson TRB. Fetal neurobehavioral development: Associations with socioeconomic class and fetal sex. Developmental Psychobiology. 1998;33(1):79–91. [PubMed] [Google Scholar]
- Raudenbush SW. HLM 6: Hierarchical linear and nonlinear modeling. Scientific Software International; 2004. [Google Scholar]
- Rieger M, Pirke K, Buske-Kirschbaum A, Wurmser H, Papousek M, Hellhammer DH. Influence of stress during pregnancy on HPA activity and neonatal behavior. Annals of the New York Academy of Sciences. 2004;1032(1):228–230. doi: 10.1196/annals.1314.026. [DOI] [PubMed] [Google Scholar]
- Robinson BG, Emanuel RL, Frim DM, Majzoub JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proceedings of the National Academy of Sciences. 1988;85(14):5244–5248. doi: 10.1073/pnas.85.14.5244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandman CA, Cordova CJ, Davis EP, Glynn LM, Buss C. Patterns of fetal heart rate response at 30 weeks gestation predict size at birth. Journal of Developmental Origins of Health and Disease. 2011;2(4):212–217. doi: 10.1017/S2040174411000250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandman CA, Davis EP. Neurobehavioral risk is associated with gestational exposure to stress hormones. Expert Review Endocrinology Metabolism. 2012;7(4):445–459. doi: 10.1586/eem.12.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandman CA, Davis EP, Glynn LM. Prescient Human Fetuses Thrive. Psychological Science. 2012;23(1):93–100. doi: 10.1177/0956797611422073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandman CA, Glynn LM, Davis EP. Is there a viability-vulnerability tradeoff? Sex differences in fetal programming. Journal of Psychosomatic Research. 2013;75(4):327–335. doi: 10.1016/j.jpsychores.2013.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandman CA, Wadhwa PD, Chicz-DeMet A, Porto M, Garite TJ. Maternal corticotropin-releasing hormone and habituation in the human fetus. Developmental Psychobiology. 1999a;34:163–173. doi: 10.1002/(sici)1098-2302(199904)34:3<163::aid-dev1>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Sandman CA, Wadhwa P, Glynn LM, Chicz-Demet A, Porto M, Garite TJ. Corticotrophin-releasing hormone and fetal responses in human pregnancy. Annals of the New York Academy of Science. 1999b;897:66–75. doi: 10.1111/j.1749-6632.1999.tb07879.x. [DOI] [PubMed] [Google Scholar]
- Schneider ML, Roughton EC, Koehler AJ, Lubach GR. Growth and development following prenatal stress exposure in primates: An examination of ontogenetic vulnerability. Child Development. 1999;70:263–274. doi: 10.1111/1467-8624.00020. [DOI] [PubMed] [Google Scholar]
- Schurmeyer TH, Avgerinos PC, Gold PW, Gallucci WT, Tomai TP, Cutler GB, Jr, et al. Chrousos GP. Human corticotropin-releasing factor in man: Pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. Journal of Clinical Endocrinology Metabolism. 1984;59(6):1103–1108. doi: 10.1210/jcem-59-6-1103. [DOI] [PubMed] [Google Scholar]
- Shiffman S, Hufford M, Hickcox M, Paty JA, Gnys M, Kassel JD. Remember that? A comparison of real-time versus retrospective recall of smoking lapses. Journal of Consulting and Clinical Psychology. 1997;65(2):292. doi: 10.1037/0022-006x.65.2.292.a. [DOI] [PubMed] [Google Scholar]
- Slotkin TA, Lappi SE, McCook EC, Tayyeb MI, Eylers JP, Seidler FJ. Glucocorticoids and the development of neuronal function: Effects of prenatal dexamethasone exposure on central noradrenergic activity. Neonatology. 1992;61(5):326–336. doi: 10.1159/000243761. [DOI] [PubMed] [Google Scholar]
- Smith TW. Hostility and health: Current status of a psychosomatic hypothesis. Health Psychology. 1992;11(3):139–150. doi: 10.1037//0278-6133.11.3.139. [DOI] [PubMed] [Google Scholar]
- Snidman N, Kagan J, Riordan L, Shannon DC. Cardiac function and behavioral reactivity during infancy. Psychophysiology. 1995;32:199–207. doi: 10.1111/j.1469-8986.1995.tb02949.x. [DOI] [PubMed] [Google Scholar]
- Spicer J, Werner E, Zhao Y, Choi CW, Lopez-Pintado S, Feng T, et al. Monk C. Ambulatory assessments of psychological and peripheral stress-markers predict birth outcomes in teen pregnancy. Journal of Psychosomatic Research. 2013;75(4):305–313. doi: 10.1016/j.jpsychores.2013.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sroufe LA, Rutter M. The domain of developmental psychopathology. Child Development. 1984:17–29. [PubMed] [Google Scholar]
- Stark MJ, Wright IM, Clifton VL. Sex-specific alterations in placental 11β-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2009;297(2):R510–R514. doi: 10.1152/ajpregu.00175.2009. [DOI] [PubMed] [Google Scholar]
- Tau GZ, Peterson BS. Normal development of brain circuits. Neuropsychopharmacology. 2010;35(1):147–168. doi: 10.1038/npp.2009.115. doi:npp2009115[pii]10.1038/npp.2009.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teixeira JMA, Fisk NM, Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: Cohort based study. British Medical Journal. 1999;318:153–157. doi: 10.1136/bmj.318.7177.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas PW, Haslum MN, MacGillivray I, Golding MJ. Does fetal heart rate predict subsequent Distress and Prenatal Development 625 heart rate in childhood? Early Human Development. 1989;19:147–152. doi: 10.1016/0378-3782(89)90125-4. [DOI] [PubMed] [Google Scholar]
- Trost SG, Loprinzi PD, Moore R, Pfeiffer KA. Comparison of accelerometer cut points for predicting activity intensity in youth. Medicine and Science in Sports and Exercise. 2011;43(7):1360–1368. doi: 10.1249/MSS.0b013e318206476e. [DOI] [PubMed] [Google Scholar]
- Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J. Neurotoxicity of glucocorticoids in the primate brain. Hormones and Behavior. 1994;28(4):336–348. doi: 10.1006/hbeh.1994.1030. [DOI] [PubMed] [Google Scholar]
- Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, Farrell PM. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Developmental Brain Research. 1990;53(2):157–167. doi: 10.1016/0165-3806(90)90002-g. [DOI] [PubMed] [Google Scholar]
- Wadhwa PD, Culhane JF, Rauh V, Barve SS. Stress and preterm birth: Neuroendocrine, immune/inflammatory, and vascular mechanisms. Maternal Child Health Journal. 2001;5(2):119–125. doi: 10.1023/a:1011353216619. [DOI] [PubMed] [Google Scholar]
- Wadhwa PD, Glynn L, Hobel CJ, Garite TJ, Porto M, Chicz-DeMet A, et al. Sandman CA. Behavioral perinatology: Biobehavioral processes in human fetal development. Regulatory Peptides. 2002;108(2–3):149–157. doi: 10.1016/s0167-0115(02)00102-7. [DOI] [PubMed] [Google Scholar]
- Ward DS, Evenson KR, Vaughn A, Rodgers AB, Troiano RP. Accelerometer use in physical activity: Best practices and research recommendations. Medicine and Science in Sports and Exercise. 2005;37:S582–S588. doi: 10.1249/01.mss.0000185292.71933.91. [DOI] [PubMed] [Google Scholar]
- Werner E, Zhao Y, Evans L, Kinsella M, Kurzius L, Altincatal A, et al. Monk C. Higher maternal prenatal cortisol and younger age predict greater infant reactivity to novelty at 4 months: An observation-based study. Developmental Psychobiology. 2013 doi: 10.1002/dev.21066. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.